In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback